More American citizens will be able to get insulin for affordable rates in 2024 as drug manufacturer Sanofi starts offering insulin products for $35 per month.
In March, Sanofi announced a cut in the price of its most widely prescribed insulin sold in the United States by 78 percent and launched a program to provide insulin for $35. These measures came into effect on Jan. 1, 2024. Sanofi has now joined other drug manufacturers like Novo Nordisk and Eli Lilly to offer insulin for $35, thus enabling more U.S. citizens to have access to affordable insulin. Eli Lilly, Sanofi, and Novo Nordisk are the three largest insulin manufacturers in the United States.
